Clinical trial
Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Multidrug Resistant Bacteria Ans Its Importance on Infectious Episodes in Hospitalized Patients
NCT03338738 is registered in ClinicalTrials.gov with Fondation Hôpital Saint-Joseph as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Multidrug Resistant Bacteria Ans Its Importance on Infectious Episodes in Hospitalized Patients
- Lead sponsor
- Fondation Hôpital Saint-Joseph
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 19, 2018
- Completion date
- May 28, 2021
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
enterobacterial infection